Wednesday, 18 January 2017

Cancer Stem Cells Market to Benefit from State Support to Cancer Assistance, Rising Cancer Morbidity Draws Attention from Public Agencies

Transparency Market Research (TMR) presents a new market study on the development of the global stem cells market from 2014 to 2020. The report is titled “Cancer Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020” and is available for sale on the company website.

The report is an in-depth analysis of trends, market growth drivers, and restraints that have a bearing on the growth of the cancer stem cells market. Using historical figures, market size projections for both revenue and volume are presented in the report. The competitive analysis of the cancer stem cells market provided in the report is useful to understand the historical hierarchy and the changing market dynamics in the regard. North America, Europe, Asia Pacific, and Rest of the World (RoW) are the regional segments into which the global cancer stem cells market is divided in this report.

Due to the rising morbidity and mortality of cancer, research activities for the prevention and treatment of the disease are on the agenda of public health agencies in many countries around the world. Government agencies and healthcare agencies are supporting these initiatives in the form of infrastructural, human resource, and monetary aid. 

In this regard, stem cells and cell therapy are slated to have a significant potential for effective cancer treatment. The efficacy of cancer stem cells (CSCs) on animals has been tested with the results obtained being significantly encouraging. However, the efficacy of CSC on humans is still in the testing phase and is facing challenges due to stringent regulatory norms and ethical constraints.

Cancer research studies demonstrate that cancer cells present inside a cancer patient’s body are not all the same. Studies suggest that within a malignant tumor or among cancerous cells that are metastasizing, the cells present are of more than one type. According to the suggestive cancer stem cell theory, among all cancerous cells, only some act as stem cells and have the potency to reproduce themselves and sustain the cancer. This is much like healthy stem cells which have the potency to renew and sustain bodily tissues and organs. In this consideration, cancer stem cells that cannot act as stem cells can also cause problems, however, these cells are not strong enough to sustain an attack on the body in the long run.

In the purview of cancer stem cell treatment, cells obtained from a tumor that can reproduce are arranged to multiply in tumors as a separate population, thereby causing deterioration the existing tumor through the development of a new tumor. With advancement in cancer stem cell research, therapies that are specific for cancer of lungs, colorectal, brain, breast, and bones, among others, will improve life-quality of cancer patients and chances of longevity with the disease.

North America is currently the largest market for cancer stem cells – developed research infrastructure, regulatory norms in place, availability of funds, and being home to a large number of skilled researchers and healthcare professionals are the reasons for this. 

Some of the major players in the business of cancer stem cells are AdnaGen Gmbh, AVIVA Biosciences Corporation, Epic Sciences Inc., Rarecells USA Inc., Advanced Cell Diagnostics Inc., Celula Inc., Fluxion Biosciences Inc. and Silicon Biosystems, S.p.A.

Browse Full Research Report on Cancer Stem Cells Market:

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

No comments:

Post a Comment